• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

companion diagnostic

blood test vials
MedTech

Guardant360-guided breast cancer therapy swaps boost survival

A new study suggests using the Guardant360 CDx test to inform a treatment change could slash the risk of breast cancer progression or death by half.
Andrea Park Jun 3, 2025 10:00am
Close-up of Benjamin Franklins eyes peering through hundred dollar bills

Caris Life Sciences collects $168M to fund tumor test rollouts

Apr 9, 2025 11:51am
Roche

Roche companion test moves into HER2-ultralow breast cancer

Feb 4, 2025 12:00pm
An artists impression of DNA The DNA appears to be made up of glowing orbs and appears on a blue background

FDA approves Caris multi-cancer companion diagnostic test

Nov 13, 2024 9:00am
AZ

AZ outlines AI-enabled TROP2 biomarker strategy for Daiichi ADC

Sep 8, 2024 12:22pm
Cancer cells reproduction

FDA OKs Illumina's tumor gene test as a companion diagnostic

Aug 28, 2024 12:00pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings